Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV13 vs PPSV23 in Japanese Elderly
NCT01646398Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2012
- Primary completion
- Oct 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Prevnar 13 in pneumococcal disease, sponsored by Pfizer. Started Jun 2012; status: completed.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT01646398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01646398.